TITLE

Study of beta blocker in post-MI bracydardia or heart block

PUB. DATE
March 2008
SOURCE
Cardiovascular Devices & Drugs;Mar2008, Vol. 14 Issue 3, p24
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the plan of Feinberg School of Medicine at Northwestern University in Evanston, Illinois to conduct a study that will investigate whether a pacemaker-enabled administration of beta-blockers in patients with post-myocardial infarction bradycardia or heart block will also improve survival rates. The study, which will enroll 1,124 pateints from around the U.S., Canada and Israel, will help determine more precisely how frequently low heart rates are a problem in heart attack patients.
ACCESSION #
31904338

 

Related Articles

  • Post-MI beta blocker doses too low. Gebhart, Fred // Drug Topics;Dec2010, Vol. 154 Issue 12, p29 

    The article presents a study on the use of pacemaker-facilitated beta blocker therapy after myocardial infarction (MI) of patients contraindicated to beta blockers, the PACE-MI trial. The study which involved MI patients from various medical centers who had beta blocker doses at discharge is...

  • Managing Heart Failure. Dec, G. William // Newsweek;10/3/2005, Vol. 146 Issue 14, p84 

    Observes that many effective treatments for heart failure have emerged in recent years. Checklist for doctors and patients; Value of an echocardiogram; Information on vasodilators; How beta blockers protect the cardiovascular system; Recommendation of an aldosterone antagonist for severe heart...

  • Effect of Beta-blockade and ACE Inhibition on B-type Natriuretic Peptides in Stable Patients with Systolic Heart Failure. Jens Rosenberg; Finn Gustafsson; Willem Remme; Günter Riegger; Per Hildebrandt // Cardiovascular Drugs & Therapy;Aug2008, Vol. 22 Issue 4, p305 

    Abstract Introduction  The long-term effect of beta-blockade on the plasma levels of natriuretic peptides BNP and its N-terminal counterpart, NT-proBNP, as risk markers in heart failure (HF) is obscure. Methods  Stable systolic HF patients from the CARMEN study...

  • Beta-blockers in heart failure. Newson, Louise // GP: General Practitioner;2/2/2007, p45 

    The article focuses on the use of beta-blockers in heart failure (HF). The author thinks that HF is a common but poorly managed condition. In the Cardiac Insufficiency Bisoprolol Trial II, the Carvedilol Prospective Randomised Cumulative Survival Study (COPERNICUS) and the Metoprolol Randomised...

  • Guidelines updated for use of perioperative β-blockade.  // PharmacoEconomics & Outcomes News;12/12/2009, Issue 593, p3 

    The article reports on the changes made to the guidelines for the clinical application of perioperative Î’-blockade. The guidelines, which was developed by the American College of Cardiology Foundation/American Heart Association (ACCF/AHA), was updated to depict the developments in the use of...

  • Drugs for elderly are not always used wisely.  // HealthFacts;Feb97, Vol. 22 Issue 2, p3 

    Reports about the under-prescription of beta-blocker drugs for the elderly who survived a heart attack. Heavy promotion of calcium channel blockers by drug companies to doctors; Association of calcium channel blockers with doubled risk of death; Percentage of patients in the study who received...

  • Avoid switching calcium antagonists for beta-blockers post-MI.  // Geriatrics;Mar97, Vol. 52 Issue 3, p16 

    Reports that the substitution of calcium antagonists for more effective beta blockers in older post-acute myocardial infarction patients results to reduced mortality, based on a study by Stephen Soumerai and colleagues. Less probability of receiving beta blockers among older patients.

  • Beta-Blocker Use in Situations Other than Just Post-MI. Kuritzky, Louis // OB/GYN Clinical Alert;Dec2012 Clinical Briefs in Primary Care, p23 

    The article discusses the use of beta-blocker for standard-of-care management of post-myocardial infraction (MI) patients.

  • 'Î’-blocker scripts are ageist'  // Pulse;6/3/2002, Vol. 62 Issue 22, p19 

    Provides information on a study which examined the role of ageism in deciding whether to prescribe β -blocker therapy to patients who have suffered a myocardial infarction. Data used in the study; Results of the study.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics